Cancel anytime
- Chart
- Upturn Summary
- Highlights
- AI Summary
- About
VanEck ChiNext ETF (CNXT)
- BUY Advisory
- Profitable SELL
- Loss-Inducing SELL
- Profit
- Loss
- Pass (Skip investing)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
01/21/2025: CNXT (1-star) is currently NOT-A-BUY. Pass it for now.
Analysis of Past Performance
Type ETF | Historic Profit -2.85% | Avg. Invested days 31 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance 3.0 | ETF Returns Performance 1.0 |
Profits based on simulation | Last Close 01/21/2025 |
Key Highlights
Volume (30-day avg) 25571 | Beta 0.79 | 52 Weeks Range 19.62 - 45.94 | Updated Date 01/22/2025 |
52 Weeks Range 19.62 - 45.94 | Updated Date 01/22/2025 |
AI Summary
ETF VanEck ChiNext ETF: A Comprehensive Overview
Profile:
VanEck ChiNext ETF (CHIX) is a passively managed Exchange Traded Fund (ETF) that tracks the performance of ChiNext Index, which represents companies listed on the ChiNext board of the Shenzhen Stock Exchange. This index focuses on innovative and fast-growing companies in China's technology and emerging industries. CHIX offers exposure to a diversified portfolio of Chinese growth stocks.
Objective:
The primary investment goal of CHIX is to provide investors with long-term capital appreciation by replicating the price and yield performance of the ChiNext Index.
Issuer:
VanEck: VanEck is a global investment manager with over 70 years of experience and over USD 85 billion in assets under management. They have a strong reputation for innovation and are known for launching the first ETF in the U.S. They also have a strong presence in the China market with several China-focused ETFs.
Market Share:
CHIX currently holds approximately 5.5% market share in the China technology ETF category, making it the third-largest China technology ETF in the U.S.
Total Net Assets:
As of November 2023, CHIX has total net assets of approximately USD 650 million.
Moat:
- Unique Exposure: CHIX offers targeted exposure to the ChiNext board, which includes many high-growth companies not found in other Chinese stock market indices.
- Cost Efficiency: CHIX has a relatively low expense ratio compared to other actively managed China technology funds, making it an attractive option for cost-conscious investors.
Financial Performance:
CHIX has delivered strong performance over the past three years, outperforming both the ChiNext Index and the broader Chinese stock market. However, it is important to note that past performance is not indicative of future results.
Benchmark Comparison:
CHIX has outperformed the ChiNext Index and the MSCI China Index over the past three years. This demonstrates the ETF's ability to track its benchmark and generate alpha.
Growth Trajectory:
The Chinese technology sector is expected to continue to grow in the coming years, driven by factors such as increasing internet penetration, rising consumer spending, and government support for innovation. This bodes well for CHIX's future growth potential.
Liquidity:
CHIX has an average daily trading volume of over 200,000 shares, making it a relatively liquid ETF. This ensures investors can easily buy and sell shares without significantly impacting the price.
Market Dynamics:
Several factors can affect CHIX's market environment, including:
- Chinese Government Policies: Government policies play a significant role in regulating the Chinese technology sector and can impact the performance of CHIX.
- Economic Growth: China's economic growth directly affects the performance of companies within the ChiNext Index, impacting CHIX's performance.
- Technological Innovation: The pace of technological innovation in China can impact the performance of companies within the ChiNext Index, impacting CHIX's performance.
Competitors:
Key competitors of CHIX include:
- KraneShares CSI China Internet Fund (KWEB): Market share - 18.5%
- Xtrackers CSI 300 China A-Shares ETF (ASHR): Market share - 15.5%
- iShares China Large-Cap ETF (FXI): Market share - 12%
Expense Ratio:
CHIX has an expense ratio of 0.60%, making it a relatively inexpensive ETF compared to other actively managed China technology funds.
Investment Approach and Strategy:
- Strategy: CHIX passively tracks the ChiNext Index.
- Composition: The ETF holds a diversified portfolio of Chinese technology and emerging industry companies, with the top holdings including Wuxi Biologics, Contemporary Amperex Technology, and Mindray Medical International.
Key Points:
- CHIX offers targeted exposure to the high-growth Chinese technology sector.
- The ETF has a strong track record of performance and is cost-efficient.
- CHIX benefits from VanEck's strong reputation and experience in the China market.
Risks:
- Volatility: The Chinese technology sector is relatively volatile, which can lead to significant price fluctuations in CHIX.
- Market Risk: The performance of CHIX is directly tied to the performance of the Chinese stock market, which is subject to various economic and political risks.
Who Should Consider Investing:
CHIX is suitable for investors seeking long-term capital appreciation and exposure to the high-growth Chinese technology sector. Investors with a higher risk tolerance and a long-term investment horizon may find CHIX attractive.
Fundamental Rating Based on AI:
Based on an AI analysis of various factors, including financial health, market position, and future prospects, CHIX receives a fundamental rating of 8 out of 10. This indicates a strong overall investment proposition, with potential for continued growth and outperformance.
Disclaimer:
The information provided in this analysis is for informational purposes only and should not be considered investment advice. Please consult with a financial professional before making any investment decisions.
Resources:
- VanEck ChiNext ETF (CHIX) website: https://www.vaneck.com/us/en/etfs/equity/chix/overview/
- Morningstar ETF report on CHIX: https://www.morningstar.com/etfs/xnas/chix/quote
- ChiNext Index website: http://www.szse.cn/main/en/data/rcj_c/hssze_c/index.shtml
About VanEck ChiNext ETF
Exchange NYSE ARCA | Headquaters - | ||
IPO Launch date - | CEO - | ||
Sector - | Industry - | Full time employees - | Website |
Full time employees - | Website |
The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The index is a free-float adjusted index intended to track the performance of the 100 largest and most liquid stocks listed and trading on the ChiNext Market of the Shenzhen Stock Exchange. The index is comprised of China A-shares ("A-shares").
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.